Published in Am J Respir Crit Care Med on June 01, 1999
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax (2001) 4.68
Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture. J Clin Microbiol (2001) 1.69
Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections. J Clin Microbiol (2003) 1.61
Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol (2005) 1.41
Evaluation of a PCR assay for detection of Streptococcus pneumoniae in respiratory and nonrespiratory samples from adults with community-acquired pneumonia. J Clin Microbiol (2003) 1.41
The role of DNA amplification technology in the diagnosis of infectious diseases. CMAJ (2000) 1.14
Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care (2011) 1.09
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis (2012) 1.08
Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis (2010) 1.07
PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol (2009) 0.99
Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. J Korean Med Sci (2006) 0.91
A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host. Thorax (2000) 0.89
Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine. Eur Respir J (2013) 0.85
Development of real-time multiplex nucleic acid sequence-based amplification for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella spp. in respiratory specimens. J Clin Microbiol (2007) 0.84
Diagnosis of pneumococcal pneumonia by psaA PCR analysis of lung aspirates from adult patients in Kenya. J Clin Microbiol (2003) 0.83
Lung biopsies for interstitial lung disease: the limits of the traditional methods of microbiological identification. Eur J Cardiothorac Surg (2012) 0.75
Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis (2002) 3.04
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60
Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37
Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA (1999) 2.16
MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol (2008) 2.14
Pulmonary infection with Nocardia species: a report of 10 cases and review. Eur Respir J (1997) 1.83
High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology (1999) 1.76
In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob Agents Chemother (1992) 1.64
International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52
Onychomadesis outbreak in Valencia, Spain, June 2008. Euro Surveill (2008) 1.39
[Mastitis caused by Nocardia brasiliensis in an immunocompetent patient]. Enferm Infecc Microbiol Clin (1997) 1.39
[Bacteremias not detected by BACTEC NR 730]. Enferm Infecc Microbiol Clin (1990) 1.38
Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig (2000) 1.37
In vitro activity of ciprofloxacin against Brucella melitensis. Eur J Clin Microbiol (1984) 1.33
Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis (2005) 1.26
Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology (2002) 1.25
De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl (2001) 1.22
Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther (2007) 1.21
Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by National Committee for Clinical Laboratory Standards method M27-A and two other methods. J Clin Microbiol (1999) 1.17
Aspergillus infections in lung transplant recipients: risk factors and outcome. Clin Microbiol Infect (2005) 1.11
Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant (2002) 1.07
[Invasive fungal infections in patients with blood disorders]. Med Clin (Barc) (1998) 1.06
Thoracic infection caused by Streptococcus milleri. Eur Respir J (1998) 1.05
Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis. Eur Respir J (1997) 0.99
Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J (2003) 0.97
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Rev Esp Quimioter (2006) 0.95
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol (1998) 0.94
Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology (1995) 0.91
[Pulmonary tuberculosis with normal chest radiography and infection by human immunodeficiency virus]. Enferm Infecc Microbiol Clin (1991) 0.90
Decrease in the volume of white matter lesions with improvement of hepatic encephalopathy. AJNR Am J Neuroradiol (2007) 0.89
Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis (2000) 0.89
Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enferm Infecc Microbiol Clin (2011) 0.89
Unexpected postmortem diagnosis of Acanthamoeba meningoencephalitis following allogeneic peripheral blood stem cell transplantation. Am J Transplant (2008) 0.89
Prognostic factors in restoration of pulmonary flow after submassive pulmonary embolism: a multiple regression analysis. Eur Respir J (1998) 0.88
Risk factors of A/H1N1 etiology in pneumonia and its impact on mortality. Respir Med (2011) 0.87
Intraphagocytic killing of gram-positive bacteria by ciprofloxacin. J Antimicrob Chemother (1994) 0.86
The evolution of the sensitivity to fosfomycin over the past two years. Chemotherapy (1977) 0.86
Repeated pulmonary infection by Nocardia asteroides complex in a patient with bronchiectasis. Respiration (1998) 0.85
[Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile]. Rev Esp Quimioter (1998) 0.85
Infectious complications in patients undergoing unrelated donor bone marrow transplantation: experience from a single institution. Clin Microbiol Infect (2002) 0.85
Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients. Eur J Cancer B Oral Oncol (1996) 0.84
Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis. Neuroscience (2001) 0.84
[Haemophilus influenzae and betalactam resistance: description of bla TEM gene deletion]. Rev Esp Quimioter (2003) 0.84
[Study of in vitro activity of caspofungin on non-Candida albicans yeast strains determined by two methods: M27-A2 and EUCAST]. Rev Esp Quimioter (2004) 0.83
Diurnal variation of serum alanine transaminase activity in chronic liver disease. Hepatology (1998) 0.83
Pigmented nail bands and mucocutaneous pigmentation in HIV-positive patients treated with zidovudine. J Am Acad Dermatol (1990) 0.82
[Usefulness of the E-test and its assay conditions in the study of the interaction of antifungal agents. A pilot study]. Rev Esp Quimioter (2004) 0.81
Fluoroderma after exposure to sevoflurane. Br J Anaesth (2011) 0.81
Enteropathogenic E. coli gastroenterocolitis in neonates treated with fosfomycin. Chemotherapy (1977) 0.81
Study of appendicitis in children treated with four different antibiotic regimens. J Pediatr Surg (1987) 0.81
Antibacterial and antifungal effects of soft contact lens disinfection solutions. Cont Lens Anterior Eye (1999) 0.80
Disseminated Blastoschizomyces capitatus infection in acute myeloblastic leukaemia. Report of three cases. Support Care Cancer (1996) 0.80
[The fungicidal activity and paradoxical effect of caspofungin against yeast. Influence of culture medium and incubation time]. Rev Esp Quimioter (2007) 0.80
Cost-effectiveness of anidulafungin in confirmed candidaemia and other invasive Candida infections in Spain. J Mycol Med (2013) 0.80
[Salmonella: resistance to 3 antibiotics of choice]. Enferm Infecc Microbiol Clin (1993) 0.79
Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis (2002) 0.79
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study]. Rev Esp Quimioter (2010) 0.79
Evaluation of xylose-galactosidase medium, a new plate for the isolation of Salmonella, Shigella, Yersinia and Aeromonas species. Eur J Clin Microbiol Infect Dis (1999) 0.79
[Cotrimoxazole plus rifampicin in the treatment of staphylococcal osteoarticular infection]. Enferm Infecc Microbiol Clin (1997) 0.79
Cefuroxime in the treatment of bacterial infections in seriously ill patients admitted to an intensive care unit. Proc R Soc Med (1977) 0.78
[Study of the betalactam resistance of Haemophilus influenzae conferred by the bla(ROB-1) gene]. Rev Esp Quimioter (2002) 0.78
[Recommendations of antifungal treatment in patients with low grade immunosuppression]. Rev Esp Quimioter (2008) 0.78
Laparoscopy and septic dissemination caused by perioperative perforation of the occluded small bowel: an experimental study. Surg Laparosc Endosc (1997) 0.78
In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study. J Chemother (1997) 0.78
[Recurrent spontaneous bacterial peritonitis due to encapsulated microorganisms (Haemophilus influenzae and Streptococcus pneumoniae) in a patient with liver cirrhosis]. Gastroenterol Hepatol (1999) 0.78
[Persistent bacteremia and infection of an intravascular device by Agrobacterium radiobacter (tumefaciens) in a boy with AIDS]. Enferm Infecc Microbiol Clin (1997) 0.78
Human intestinal infection due to coccidia in Mozambique: two cases. Acta Trop (1999) 0.77
Visceral leishmaniasis in lung transplantation. Transplant Proc (2003) 0.77
Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms. Chemotherapy (1999) 0.77
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol (1995) 0.77
[In vitro activity of voriconazole against yeast and algae isolates according to new resistance pattern cut-off points]. Rev Esp Quimioter (2006) 0.77
Brucellar prosthetic arthritis in a total knee replacement. Eur J Clin Microbiol Infect Dis (1997) 0.77
Imipenem in the treatment of severe bacterial infections in seriously ill patients. J Antimicrob Chemother (1986) 0.77
[In vitro activity of posaconazole against yeasts isolated in blood cultures]. Rev Esp Quimioter (2002) 0.77
Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol (1995) 0.77
[Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. Rev Esp Quimioter (2006) 0.77
[Neonatal colonization by Ureaplasma urealyticum and the development of bronchopulmonary dysplasia]. Enferm Infecc Microbiol Clin (1999) 0.76
New studies on placental transfer of fosfomycin. Chemotherapy (1977) 0.76
[Recommendations in the empiric anti-infective agents of intra-abdominal infection]. Rev Esp Quimioter (2009) 0.76
[Detection of cytomegalovirus in urine by the shell-vial technique: usefulness of diluting the sample]. Enferm Infecc Microbiol Clin (1991) 0.76
Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J Hepatol (2001) 0.76
[Acute viral infections in immunocompetent patients]. Med Intensiva (2011) 0.76
Pancreatic pseudocyst located in the liver. Rev Esp Enferm Dig (2006) 0.76
Antimicrobial activity of benzylisoquinoline alkaloids. Pharmazie (1987) 0.76
[Epidemiology of genotypic resistance of HIV-1 in Valencia. A 4-year study]. Rev Esp Quimioter (2007) 0.76
Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group. Chemotherapy (1989) 0.76
Infected total hip arthroplasty--the value of intraoperative histology. Int Orthop (1999) 0.76
[Patient consent to "antimicrobial treatment of tonsillitis"]. Acta Otorrinolaringol Esp (2003) 0.75